Answers are grounded in this paper and cite their sources.
Twelve-month MIRROR RCT data further support MTX cotherapy with pegloticase. Tophi resolution continued to increase through week 52, suggesting continued therapeutic benefit beyond month 6 for a favorable treatment effect.
No takes yet. Share an insight, caveat, or question.
Botson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: